CardioVascular Center for Research and Innovation (CVCRI)

Publications

Since January 2018, the CardioVascular Center has published numerous reports in peer-reviewed journals. These are the highlighted high-impact manuscripts from this quarter.

Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani FD, Raval AN, Ward C; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018 May 15;137(20):e578-e622.


Published in Circulation (Impact Factor: 19). This consensus statement from the American Heart Association led by Drs. Konstam and Kiernan provides penetrating insight into the problem of right heart failure, which is a major cause of global morbidity and mortality for millions of individuals worldwide.

Morine KJ, Qiao X, York S, Natov PS, Paruchuri V, Zhang Y, Aronovitz MJ, Karas RH, Kapur NK. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure. Circulation. 2018 Feb 27. pii:CIRCULATIONAHA.117.031635.

Published in Circulation (Impact Factor: 19). This original research report from led by Dr. Morine, an interventional cardiology fellow at Tufts Medical Center, introduces a new protein that regulates heart failure and may be a novel target of therapy for drug development. This work represents the culmination of Dr. Morine's research as a recipient of an award from the National Institutes of Health T-32 Post-doctoral Fellowship Program in Dr. Kapur’s Lab. The report was also highlighted in Nature Cardiovascular Medicine as pioneering work.


Wells S, Rowin EJ, Bhatt V, Maron MS, Maron BJ. Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy. Circulation. 2018 May 1;137(18):1973-1975.

Published in Circulation (Impact Factor: 19). This original research report identified that African American patients with HCM may be under-recognized and under-referred for effective therapies such as surgical myectomy or implantable cardioverter defibrillators because of potential racial disparities in access to specialty HCM care.

I. Cardiology (Adult)

1: Adamson PD, Fordyce CB, McAllister DA, Udelson JE, Douglas PS, Newby DE.
Identification of patients with stable chest pain deriving minimal value from
coronary computed tomography angiography: An external validation of the PROMISE
minimal-risk tool. Int J Cardiol. 2018 Feb 1;252:31-34. doi:
10.1016/j.ijcard.2017.09.033. PubMed PMID: 29249436; PubMed Central PMCID:
PMC5761719.

2: Agrawal S, Garg L, Shah M, Agarwal M, Patel B, Singh A, Garg A, Jorde UP,
Kapur NK. Thirty-Day Readmissions After Left Ventricular Assist Device
Implantation in the United States: Insights From the Nationwide Readmissions
Database. Circ Heart Fail. 2018 Mar;11(3):e004628. doi:
10.1161/CIRCHEARTFAILURE.117.004628. PubMed PMID: 29519902.

3: Aljabri K, Garlitski A, Weinstock J, Madias C. Management of Device
Infections. Card Electrophysiol Clin. 2018 Mar;10(1):153-162. doi:
10.1016/j.ccep.2017.11.016. Review. PubMed PMID: 29428137.

4: Allen LA, Adler ED, Bayés-Genis A, Brisco-Bacik MA, Chirinos JA, Claggett B,
Cook JL, Fang JC, Gustafsson F, Ho CY, Kapur NK, Klewer SE, Kociol RD, Lanfear
DE, Vardeny O, Sweitzer NK. When the VEST Does Not Fit: Representations of Trial
Results Deviating From Rigorous Data Interpretation. Circ Heart Fail. 2018
Apr;11(4):e005116. doi: 10.1161/CIRCHEARTFAILURE.118.005116. PubMed PMID:
29666074.

5: Bamberg F, Mayrhofer T, Ferencik M, Bittner DO, Hallett TR, Janjua S, Schlett
CL, Nagurney JT, Udelson JE, Truong QA, Woodard PK, Hollander JE, Litt H,
Hoffmann U. Age- and sex-based resource utilisation and costs in patients with
acute chest pain undergoing cardiac CT angiography: pooled evidence from ROMICAT
II and ACRIN-PA trials. Eur Radiol. 2018 Feb;28(2):851-860. doi:
10.1007/s00330-017-4981-y. Epub 2017 Sep 5. PubMed PMID: 28875364.

6: Baugh LM, Liu Z, Quinn KP, Osseiran S, Evans CL, Huggins GS, Hinds PW, Black
LD, Georgakoudi I. Non-destructive two-photon excited fluorescence imaging
identifies early nodules in calcific aortic-valve disease. Nat Biomed Eng. 2017
Nov;1(11):914-924. doi: 10.1038/s41551-017-0152-3. Epub 2017 Nov 6. PubMed PMID:
29456878; PubMed Central PMCID: PMC5811202.

7: Bledsoe JR, Woller SC, Stevens SM, Aston V, Patten R, Allen T, Horne BD, Dong
L, Lloyd J, Snow G, Madsen T, Elliott CG. Management of Low-Risk Pulmonary
Embolism Patients Without Hospitalization: The Low-Risk Pulmonary Embolism
Prospective Management Study. Chest. 2018 Feb 2. pii: S0012-3692(18)30231-9. doi:
10.1016/j.chest.2018.01.035. [Epub ahead of print] PubMed PMID: 29410163.

8: Brinkley DM, DeNofrio D, Ruthazer R, Vest AR, Kapur NK, Couper GS, Kiernan MS.
Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as
Destination Therapy at Transplant Versus Nontransplant Centers. Circ Heart Fail.
2018 Mar;11(3):e004384. doi: 10.1161/CIRCHEARTFAILURE.117.004384. PubMed PMID:
29540471.

9: Cheng J, Tao F, Liu Y, Venners SA, Hsu YH, Jiang S, Weinstock J, Wang B, Tang
G, Xu X. Associations of methylenetetrahydrofolate reductase C677T genotype with
blood pressure levels in Chinese population with essential hypertension. Clin Exp
Hypertens. 2018;40(3):207-212. doi: 10.1080/10641963.2017.1281937. Epub 2018 Feb
13. PubMed PMID: 29436860.

10: Davel AP, Lu Q, Moss ME, Rao S, Anwar IJ, DuPont JJ, Jaffe IZ. Sex-Specific
Mechanisms of Resistance Vessel Endothelial Dysfunction Induced by
Cardiometabolic Risk Factors. J Am Heart Assoc. 2018 Feb 16;7(4). pii: e007675.
doi: 10.1161/JAHA.117.007675. PubMed PMID: 29453308; PubMed Central PMCID:
PMC5850194.

11: Davila CD, Udelson JE. Trials and Tribulations of Assessing
New Imaging Protocols: Combining Vasodilator Stress With Exercise. JACC
Cardiovasc Imaging. 2018 Mar;11(3):494-504. doi: 10.1016/j.jcmg.2017.12.005.
Review. PubMed PMID: 29519339.

12: Dinca AA, Chien WM, Chin MT. Identification of novel mitochondrial
localization signals in human Tafazzin, the cause of the inherited
cardiomyopathic disorder Barth syndrome. J Mol Cell Cardiol. 2018 Jan;114:83-92.
doi: 10.1016/j.yjmcc.2017.11.005. Epub 2017 Nov 10. PubMed PMID: 29129703; PubMed
Central PMCID: PMC5801207.

13: Elsayes AH, Joshi B, Wessler B, Rowin EJ, Maron MS, Cobey FC. A Case of
Multiple Ventricular Gradients. J Cardiothorac Vasc Anesth. 2018 Jan 31. pii:
S1053-0770(18)30027-2. doi: 10.1053/j.jvca.2018.01.023. [Epub ahead of print]
PubMed PMID: 29459110.

14: Esposito ML, Jablonski J, Kras A, Krasney S, Kapur NK. Maximum level of
mobility with axillary deployment of the Impella 5.0 is associated with improved
survival. Int J Artif Organs. 2018 Apr;41(4):236-239. doi:
10.1177/0391398817752575. Epub 2018 Feb 20. PubMed PMID: 29637832.

15: Estes NAM 3rd, Maron BJ. Defibrillation threshold testing in hypertrophic
cardiomyopathy: As SIMPLE as possible but not simpler. Heart Rhythm. 2018
Mar;15(3):393-394. doi: 10.1016/j.hrthm.2017.12.010. Epub 2017 Dec 8. PubMed
PMID: 29229517.

16: Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT, Meyersohn
NM, Ivanov AV, Adami EC, Patel MR, Mark DB, Udelson JE, Lee KL, Douglas PS,
Hoffmann U. Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk
Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the
PROMISE Randomized Clinical Trial. JAMA Cardiol. 2018 Feb 1;3(2):144-152. doi:
10.1001/jamacardio.2017.4973. PubMed PMID: 29322167; PubMed Central PMCID:
PMC5838601.

17: Freytsis M, Baugh L, Liu Z, Georgakoudi I, Hinds PW, Black LD, Huggins GS.
Conditional deletion of RB1 in the Tie2 lineage leads to aortic valve
regurgitation. PLoS One. 2018 Jan 5;13(1):e0190623. doi:
10.1371/journal.pone.0190623. eCollection 2018. PubMed PMID: 29304157; PubMed
Central PMCID: PMC5755794.

18: Goldsmith SR, Udelson JE, Gheorghiade M. Dual Vasopressin V1a/V2 Antagonism:
The Next Step in Neurohormonal Modulation in Patients With Heart Failure? J Card
Fail. 2018 Feb;24(2):112-114. doi: 10.1016/j.cardfail.2017.12.011. Epub 2018 Jan
9. PubMed PMID: 29329950.

19: Good ME, Chiu YH, Poon IKH, Medina CB, Butcher JT, Mendu SK, DeLalio LJ,
Lohman AW, Leitinger N, Barrett E, Lorenz UM, Desai BN, Jaffe IZ, Bayliss DA,
Isakson BE, Ravichandran KS. Pannexin 1 Channels as an Unexpected New Target of
the Anti-Hypertensive Drug Spironolactone. Circ Res. 2018 Feb 16;122(4):606-615.
doi: 10.1161/CIRCRESAHA.117.312380. Epub 2017 Dec 13. PubMed PMID: 29237722;
PubMed Central PMCID: PMC5815904.

20: Gosev I, Kiernan MS, Eckman P, Soleimani B, Kilic A, Uriel N, Rich JD, Katz
JN, Cowger J, Lima B, McGurk S, Brisco-Bacik MA, Lee S, Joseph SM, Patel CB;
Evolving Mechanical Support Research Group (EMERG) Investigators. Long-Term
Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device.
Ann Thorac Surg. 2018 Mar;105(3):696-701. doi: 10.1016/j.athoracsur.2017.08.057.
Epub 2017 Dec 2. Erratum in: Ann Thorac Surg. 2018 Apr;105(4):1284. PubMed PMID: 29198630.

21: Kagemoto Y, Weintraub A, Pandian NG, Rastegar H, Halin N, Cobey FC. Late
Clinical Presentation of Prosthesis-Patient Mismatch Following Transcatheter
Aortic Valve Replacement. J Cardiothorac Vasc Anesth. 2018 Mar 6. pii:
S1053-0770(18)30193-9. doi: 10.1053/j.jvca.2018.03.005. [Epub ahead of print]
PubMed PMID: 29631945.

22: Kiernan MS, Stevens SR, Tang WHW, Butler J, Anstrom KJ, Birati EY, Grodin JL,
Gupta D, Margulies KB, LaRue S, Dávila-Román VG, Hernandez AF, de Las Fuentes L;
NHLBI Heart Failure Clinical Trials Network Investigators. Determinants of
Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure
Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical
Trials. J Card Fail. 2018 Mar 1. pii: S1071-9164(18)30066-6. doi:
10.1016/j.cardfail.2018.02.002. [Epub ahead of print] PubMed PMID: 29482026.

23: Kim SK, McCurley AT, DuPont JJ, Aronovitz M, Moss ME, Stillman IE, Karumanchi
SA, Christou DD, Jaffe IZ. Smooth Muscle Cell-Mineralocorticoid Receptor as a
Mediator of Cardiovascular Stiffness With Aging. Hypertension. 2018
Apr;71(4):609-621. doi: 10.1161/HYPERTENSIONAHA.117.10437. Epub 2018 Feb 20.
PubMed PMID: 29463624; PubMed Central PMCID: PMC5843545.

24: Konstam MA. Heart Failure Costs, Minority Populations, and Outcomes:
Targeting Health Status, Not Utilization, to Bend the Cost-Effectiveness Curve.
JACC Heart Fail. 2018 Apr 5. pii: S2213-1779(18)30135-5. doi:
10.1016/j.jchf.2018.02.005. [Epub ahead of print] PubMed PMID: 29655823.

25: Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD,
Lewis EF, Mehra MR, Pagani FD, Raval AN, Ward C; American Heart Association
Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young;
and Council on Cardiovascular Surgery and Anesthesia. Evaluation and Management
of Right-Sided Heart Failure: A Scientific Statement From the American Heart
Association. Circulation. 2018 Apr 12. pii: CIR.0000000000000560. doi:
10.1161/CIR.0000000000000560. [Epub ahead of print] Review. PubMed PMID:
29650544.

26: Madias C, Estes NAM 3rd. Class IC antiarrhythmic agents in structural heart
disease: Is nothing CAST in stone? Heart Rhythm. 2018 Feb;15(2):164-165. doi:
10.1016/j.hrthm.2017.12.021. PubMed PMID: 29405948.

27: Madias C, Maron BJ, Dau N, Estes NAM 3rd, Bir C, Link MS. Size as an
Important Determinant of Chest Blow-induced Commotio Cordis. Med Sci Sports
Exerc. 2018 Apr 3. doi: 10.1249/MSS.0000000000001630. [Epub ahead of print]
PubMed PMID: 29620687.

28: Margoles L, DeNofrio D, Patel AR, Golan Y, Vest AR, Arkun K, Boucher HW,
Kiernan MS, Upshaw JN. Disseminated mucormycosis masquerading as rejection early
after orthotopic heart transplantation. Transpl Infect Dis. 2018 Feb;20(1). doi:
10.1111/tid.12820. Epub 2018 Jan 16. PubMed PMID: 29172240.

29: Maron BJ, Rowin EJ, Udelson JE, Maron MS. Clinical Spectrum and
Management of Heart Failure in Hypertrophic Cardiomyopathy. JACC Heart Fail. 2018
Apr 5. pii: S2213-1779(17)30634-0. doi: 10.1016/j.jchf.2017.09.011. [Epub ahead
of print] Review. PubMed PMID: 29655822.

30: Maron BJ, Estes NAM 3rd, Maron MS. Is It Fair to Screen Only Competitive
Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field? Am J
Cardiol. 2018 Apr 15;121(8):1008-1010. doi: 10.1016/j.amjcard.2017.12.043. Epub
2018 Jan 31. PubMed PMID: 29472006.

31: Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, Ahmed A,
Boriani G, Francia P, Winters SL, Giudici M, Koulova A, Garberich R, Rowin EJ,
Sears SF, Maron MS, Spirito P. Clinical Course and Quality of Life in High-Risk
Patients With Hypertrophic Cardiomyopathy and Implantable
Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol. 2018
Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820. PubMed PMID: 29625970.

32: Maron MS, Chan RH, Kapur NK, Jaffe IJ, McGraw AP, Kerur R, Maron BJ, Udelson
JE. Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables
in Patients with Hypertrophic Cardiomyopathy: a Prospective, Randomized Trial. Am
J Med. 2018 Mar 28. pii: S0002-9343(18)30223-7. doi:
10.1016/j.amjmed.2018.02.025. [Epub ahead of print] PubMed PMID: 29604289.

33: Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, Desnick RJ, Maron BJ.
Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with
Hypertrophic Cardiomyopathy. Am J Med. 2018 Feb;131(2):200.e1-200.e8. doi:
10.1016/j.amjmed.2017.09.010. Epub 2017 Sep 21. PubMed PMID: 28943383.

34: Mirhashemi ME, Noubary F, Chapman-Bonofiglio S, Tzipori S, Huggins GS, Widmer
G. Transcriptome analysis of pig intestinal cell monolayers infected with
Cryptosporidium parvum asexual stages. Parasit Vectors. 2018 Mar 12;11(1):176.
doi: 10.1186/s13071-018-2754-3. PubMed PMID: 29530089; PubMed Central PMCID:
PMC5848449.

35: Morine KJ, Qiao X, York S, Natov PS, Paruchuri V, Zhang Y, Aronovitz MJ,
Karas RH, Kapur NK. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and
Improves Cardiac Function in Heart Failure. Circulation. 2018 Feb 27. pii:
CIRCULATIONAHA.117.031635. doi: 10.1161/CIRCULATIONAHA.117.031635. [Epub ahead of
print] PubMed PMID: 29487140.

36: Mulhauser K, Weinstock J, Ruppert P, Benware J. Changes in Neuropsychological
Status during the Initial Phase of Abstinence in Alcohol Use Disorder:
Neurocognitive Impairment and Implications for Clinical Care. Subst Use Misuse.
2018 May 12;53(6):881-890. doi: 10.1080/10826084.2017.1408328. Epub 2018 Jan 2.
PubMed PMID: 29293037.

37: Olchanski N, Vest AR, Cohen JT, Neumann PJ, DeNofrio D. Cost comparison
across heart failure patients with reduced and preserved ejection fractions:
Analyses of inpatient decompensated heart failure admissions. Int J Cardiol. 2018
Jun 15;261:103-108. doi: 10.1016/j.ijcard.2018.03.024. PubMed PMID: 29657034.

38: Patel NJ, Patel N, Bhardwaj B, Golwala H, Kumar V, Atti V, Arora S, Patel S,
Patel N, Hernandez GA, Badheka A, Alfonso CE, Cohen MG, Bhatt DL, Kapur NK.
Trends in utilization of mechanical circulatory support in patients hospitalized
after out-of-hospital cardiac arrest. Resuscitation. 2018 Apr 16;127:105-113.
doi: 10.1016/j.resuscitation.2018.04.007. [Epub ahead of print] PubMed PMID:
29674141.

39: Roehm B, Vest AR, Weiner DE. Left Ventricular Assist Devices, Kidney Disease,
and Dialysis. Am J Kidney Dis. 2018 Feb;71(2):257-266. doi:
10.1053/j.ajkd.2017.09.019. Epub 2017 Dec 14. PubMed PMID: 29249390.

40: Rowin EJ, Maron BJ, Abt P, Kiernan MS, Vest A, Costantino F, Maron MS,
DeNofrio D. Impact of Advanced Therapies for Improving Survival to Heart
Transplant in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Apr
15;121(8):986-996. doi: 10.1016/j.amjcard.2017.12.044. Epub 2018 Jan 31. PubMed: 29496192.

41: Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S, Dziewięcka E, Kołton-Wróż M,
Wołkow P, Pitera E, Rudnicka-Sosin L, Garlitski AC, Gackowski A, Podolec P. The
relationship between myocardial fibrosis and myocardial microRNAs in dilated
cardiomyopathy: A link between mir-133a and cardiovascular events. J Cell Mol
Med. 2018 Apr;22(4):2514-2517. doi: 10.1111/jcmm.13535. Epub 2018 Jan 29. PubMed
PMID: 29377565; PubMed Central PMCID: PMC5867126.

42: Serafini N, Sharma PS, Madias C, Trohman RG. Wide complex tachycardia in a
patient with congenital heart block: What is the mechanism? J Cardiovasc
Electrophysiol. 2018 Jan;29(1):201-203. doi: 10.1111/jce.13340. Epub 2017 Oct 3.
PubMed PMID: 28940430.

43: Shah M, Patil S, Patel B, Agarwal M, Davila CD, Garg L, Agrawal S, Kapur NK,
Jorde UP. Causes and Predictors of 30-Day Readmission in Patients With Acute
Myocardial Infarction and Cardiogenic Shock. Circ Heart Fail. 2018
Apr;11(4):e004310. doi: 10.1161/CIRCHEARTFAILURE.117.004310. PubMed PMID:
29618581.

44: Solomon Z, Breton C, Rowin EJ, Maron BJ, Maron MS, Chen FY, Rastegar H.
Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy. Semin Thorac
Cardiovasc Surg. 2018 Mar 7. pii: S1043-0679(18)30080-7. doi:
10.1053/j.semtcvs.2018.02.034. [Epub ahead of print] PubMed PMID: 29524602.

45: Udelson JE. The Changing Face of Heart Failure. JACC Cardiovasc Imaging. 2018
Jan;11(1):12-14. doi: 10.1016/j.jcmg.2017.08.010. Epub 2017 Sep 13. PubMed PMID:
28917691.

46: Van Patten R, Weinstock J, McGrath AB. Health Outcomes in Individuals with
Problem and Pathological Gambling: An Analysis of the 2014 North Carolina
Behavioral Risk Factor Survey System (BRFSS). J Gambl Stud. 2018
Mar;34(1):297-306. doi: 10.1007/s10899-017-9712-4. PubMed PMID: 28864873.

47: Vest AR. Has the Time Come to Be More Aggressive With Bariatric Surgery in
Obese Patients With Chronic Systolic Heart Failure? Curr Heart Fail Rep. 2018 Apr
8. doi: 10.1007/s11897-018-0390-z. [Epub ahead of print] Review. PubMed PMID:
29629485.

48: Watanabe S, Fish K, Kovacic JC, Bikou O, Leonardson L, Nomoto K, Aguero J,
Kapur NK, Hajjar RJ, Ishikawa K. Left Ventricular Unloading Using an Impella CP
Improves Coronary Flow and Infarct Zone Perfusion in Ischemic Heart Failure. J Am
Heart Assoc. 2018 Mar 7;7(6). pii: e006462. doi: 10.1161/JAHA.117.006462. Erratum
in: J Am Heart Assoc. 2018 Apr 23;7(9):. PubMed PMID: 29514806.

49: Weinstock J. Use of the Wearable Cardioverter Defibrillator as a Bridge to
Implantable Cardioverter Defibrillator. Card Electrophysiol Clin. 2018
Mar;10(1):11-16. doi: 10.1016/j.ccep.2017.11.002. Review. PubMed PMID: 29428131.

50: Wells S, Rowin EJ, Boll G, Rastegar H, Wang W, Maron MS, Maron BJ. Clinical
Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic
Cardiomyopathy. Am J Med. 2018 Jan 31. pii: S0002-9343(18)30021-4. doi:
10.1016/j.amjmed.2017.12.031. [Epub ahead of print] PubMed PMID: 29353047.

51: Wu J, Kumar S, Wang F, Wang H, Chen L, Arsenault P, Mattern M, Weinstock J.
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7)
Function for Oncology and Immune Oncology Therapies. J Med Chem. 2018 Jan
25;61(2):422-443. doi: 10.1021/acs.jmedchem.7b00498. Epub 2017 Aug 18. PubMed
PMID: 28768102.

52: Zhang KW, Finkelman BS, Gulati G, Narayan HK, Upshaw J, Narayan V, Plappert
T, Englefield V, Smith AM, Zhang C, Hundley WG, Ky B. Abnormalities in
3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are
Associated With Systolic and Diastolic Dysfunction. JACC Cardiovasc Imaging. 2018
Mar 9. pii: S1936-878X(18)30122-0. doi: 10.1016/j.jcmg.2018.01.015. [Epub ahead of print] PubMed PMID: 29550306.

52: Olchanski N, Vest AR, Cohen JT, Neumann PJ, DeNofrio D. Cost comparison
across heart failure patients with reduced and preserved ejection fractions:
Analyses of inpatient decompensated heart failure admissions. Int J Cardiol. 2018
Jun 15;261:103-108. doi: 10.1016/j.ijcard.2018.03.024. PubMed PMID: 29657034.
53: Patel NJ, Patel N, Bhardwaj B, Golwala H, Kumar V, Atti V, Arora S, Patel S,
Patel N, Hernandez GA, Badheka A, Alfonso CE, Cohen MG, Bhatt DL, Kapur NK.
Trends in utilization of mechanical circulatory support in patients hospitalized
after out-of-hospital cardiac arrest. Resuscitation. 2018 Jun;127:105-113. doi:
10.1016/j.resuscitation.2018.04.007. Epub 2018 Apr 16. PubMed PMID: 29674141.

54: Puchner SB, Mayrhofer T, Park J, Lu MT, Liu T, Maurovich-Horvat P, Ghemigian
K, Bittner DO, Fleg JL, Udelson JE, Truong QA, Hoffmann U, Ferencik M.
Differences in the association of total versus local coronary artery calcium with
acute coronary syndrome and culprit lesions in patients with acute chest pain:
The coronary calcium paradox. Atherosclerosis. 2018 Jul;274:251-257. doi:
10.1016/j.atherosclerosis.2018.04.017. Epub 2018 Apr 17. PubMed PMID: 29703635;
PubMed Central PMCID: PMC5999579.

55: Roehm B, Vest AR, Weiner DE. Left Ventricular Assist Devices, Kidney Disease,
and Dialysis. Am J Kidney Dis. 2018 Feb;71(2):257-266. doi:
10.1053/j.ajkd.2017.09.019. Epub 2017 Dec 14. PubMed PMID: 29249390.
56: Rogers PA, Bernard ML, Madias C, Thihalolipavan S, Mark Estes NA 3rd, Morin
DP. Current Evidence-Based Understanding of the Epidemiology, Prevention, and
Treatment of Atrial Fibrillation. Curr Probl Cardiol. 2018 Jun;43(6):241-283.
doi: 10.1016/j.cpcardiol.2017.06.001. Epub 2017 Jun 7. PubMed PMID: 29759117.

57: Rowin EJ, Maron MS, Maron BJ. Response by Rowin et al to Letter Regarding
Article, "Clinical Profile and Consequences of Atrial Fibrillation in
Hypertrophic Cardiomyopathy". Circulation. 2018 Jun 5;137(23):2541-2542. doi:
10.1161/CIRCULATIONAHA.118.034857. PubMed PMID: 29866781.

58: Rowin EJ, Maron BJ, Chokshi A, Maron MS. Left ventricular apical aneurysm in
hypertrophic cardiomyopathy as a risk factor for sudden death at any age. Pacing
Clin Electrophysiol. 2018 Jun 12. doi: 10.1111/pace.13413. [Epub ahead of print]
Review. PubMed PMID: 29893504.
59: Rowin EJ, Maron BJ, Abt P, Kiernan MS, Vest A, Costantino F, Maron MS,
DeNofrio D. Impact of Advanced Therapies for Improving Survival to Heart
Transplant in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 Apr
15;121(8):986-996. doi: 10.1016/j.amjcard.2017.12.044. Epub 2018 Jan 31. PubMed
PMID: 29496192.

60: Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S, Dziewięcka E, Kołton-Wróż M,
Wołkow P, Pitera E, Rudnicka-Sosin L, Garlitski AC, Gackowski A, Podolec P. The
relationship between myocardial fibrosis and myocardial microRNAs in dilated
cardiomyopathy: A link between mir-133a and cardiovascular events. J Cell Mol
Med. 2018 Apr;22(4):2514-2517. doi: 10.1111/jcmm.13535. Epub 2018 Jan 29. PubMed
PMID: 29377565; PubMed Central PMCID: PMC5867126.

61: Serafini N, Sharma PS, Madias C, Trohman RG. Wide complex tachycardia in a
patient with congenital heart block: What is the mechanism? J Cardiovasc
Electrophysiol. 2018 Jan;29(1):201-203. doi: 10.1111/jce.13340. Epub 2017 Oct 3.
PubMed PMID: 28940430.

62: Shah M, Patil S, Patel B, Agarwal M, Davila CD, Garg L, Agrawal S, Kapur NK,
Jorde UP. Causes and Predictors of 30-Day Readmission in Patients With Acute
Myocardial Infarction and Cardiogenic Shock. Circ Heart Fail. 2018
Apr;11(4):e004310. doi: 10.1161/CIRCHEARTFAILURE.117.004310. PubMed PMID:
29618581.

63: Shukri MZ, Tan JW, Manosroi W, Pojoga LH, Rivera A, Williams JS, Seely EW,
Adler GK, Jaffe IZ, Karas RH, Williams GH, Romero JR. Biological Sex Modulates
the Adrenal and Blood Pressure Responses to Angiotensin II. Hypertension. 2018
Jun;71(6):1083-1090. doi: 10.1161/HYPERTENSIONAHA.117.11087. Epub 2018 Apr 23.
PubMed PMID: 29686001.

64: Solomon Z, Breton C, Rowin EJ, Maron BJ, Maron MS, Chen FY, Rastegar H.
Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy. Semin Thorac
Cardiovasc Surg. 2018 Mar 7. pii: S1043-0679(18)30080-7. doi:
10.1053/j.semtcvs.2018.02.034. [Epub ahead of print] PubMed PMID: 29524602.

65: Tandan S, Meltzer SN, Davila CD, Konstam MA, LeWinter MM. Eosinophilic
Myocarditis With Rapid Progression to Cardiogenic Shock, Managed With Mechanical
Support and High-Dose Corticosteroids. Circ Heart Fail. 2018 Jun;11(6):e004910.
doi: 10.1161/CIRCHEARTFAILURE.118.004910. PubMed PMID: 29848515.

66: Udelson JE. The Changing Face of Heart Failure. JACC Cardiovasc Imaging. 2018
Jan;11(1):12-14. doi: 10.1016/j.jcmg.2017.08.010. Epub 2017 Sep 13. PubMed PMID:
28917691.

67: Upshaw JN, van Klaveren D, Konstam MA, Kent DM. Digoxin Benefit Varies by
Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model. Am J
Med. 2018 Jun;131(6):676-683.e2. doi: 10.1016/j.amjmed.2017.12.010. Epub 2017 Dec
25. PubMed PMID: 29284111.

68: Vaduganathan M, Patel RB, Mentz RJ, Subacius H, Chatterjee NA, Greene SJ,
Ambrosy AP, Maggioni AP, Udelson JE, Swedberg K, Konstam MA, O'Connor CM, Butler
J, Gheorghiade M, Zannad F. Sudden Death After Hospitalization for Heart Failure
With Reduced Ejection Fraction (from the EVEREST Trial). Am J Cardiol. 2018 Jul
15;122(2):255-260. doi: 10.1016/j.amjcard.2018.03.362. Epub 2018 Apr 11. PubMed
PMID: 29731121; PubMed Central PMCID: PMC6028287.

69: Vest AR. Has the Time Come to Be More Aggressive With Bariatric Surgery in
Obese Patients With Chronic Systolic Heart Failure? Curr Heart Fail Rep. 2018
Jun;15(3):171-180. doi: 10.1007/s11897-018-0390-z. Review. PubMed PMID: 29629485.

70: Watanabe S, Fish K, Kovacic JC, Bikou O, Leonardson L, Nomoto K, Aguero J,
Kapur NK, Hajjar RJ, Ishikawa K. Left Ventricular Unloading Using an Impella CP
Improves Coronary Flow and Infarct Zone Perfusion in Ischemic Heart Failure. J Am
Heart Assoc. 2018 Mar 7;7(6). pii: e006462. doi: 10.1161/JAHA.117.006462. Erratum
in: J Am Heart Assoc. 2018 Apr 23;7(9):. PubMed PMID: 29514806; PubMed Central
PMCID: PMC5907535.

71: Weinstock J. Use of the Wearable Cardioverter Defibrillator as a Bridge to
Implantable Cardioverter Defibrillator. Card Electrophysiol Clin. 2018
Mar;10(1):11-16. doi: 10.1016/j.ccep.2017.11.002. Review. PubMed PMID: 29428131.

72: Wells S, Rowin EJ, Bhatt V, Maron MS, Maron BJ. Association Between Race and
Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy.
Circulation. 2018 May 1;137(18):1973-1975. doi:
10.1161/CIRCULATIONAHA.117.032838. PubMed PMID: 29712699.

73: Wells S, Rowin EJ, Boll G, Rastegar H, Wang W, Maron MS, Maron BJ. Clinical
Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic
Cardiomyopathy. Am J Med. 2018 Jun;131(6):e235-e239. doi:
10.1016/j.amjmed.2017.12.031. Epub 2018 Jan 31. PubMed PMID: 29353047.

74: Wu J, Kumar S, Wang F, Wang H, Chen L, Arsenault P, Mattern M, Weinstock J.
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7)
Function for Oncology and Immune Oncology Therapies. J Med Chem. 2018 Jan
25;61(2):422-443. doi: 10.1021/acs.jmedchem.7b00498. Epub 2017 Aug 18. PubMed
PMID: 28768102.

75: Zhang KW, Finkelman BS, Gulati G, Narayan HK, Upshaw J, Narayan V, Plappert
T, Englefield V, Smith AM, Zhang C, Hundley WG, Ky B. Abnormalities in
3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are
Associated With Systolic and Diastolic Dysfunction. JACC Cardiovasc Imaging. 2018
Mar 9. pii: S1936-878X(18)30122-0. doi: 10.1016/j.jcmg.2018.01.015. [Epub ahead
of print] PubMed PMID: 29550306.

II. Cardiac Surgery

1: Brinkley DM, DeNofrio D, Ruthazer R, Vest AR, Kapur NK, Couper GS, Kiernan MS.
Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as
Destination Therapy at Transplant Versus Nontransplant Centers. Circ Heart Fail.
2018 Mar;11(3):e004384. doi: 10.1161/CIRCHEARTFAILURE.117.004384. PubMed PMID:
29540471.

2: Kagemoto Y, Weintraub A, Pandian NG, Rastegar H, Halin N, Cobey FC. Late
Clinical Presentation of Prosthesis-Patient Mismatch Following Transcatheter
Aortic Valve Replacement. J Cardiothorac Vasc Anesth. 2018 Mar 6. pii:
S1053-0770(18)30193-9. doi: 10.1053/j.jvca.2018.03.005. [Epub ahead of print]
PubMed PMID: 29631945.

3: Solomon Z, Breton C, Rowin EJ, Maron BJ, Maron MS, Chen FY, Rastegar H.
Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy. Semin Thorac
Cardiovasc Surg. 2018 Mar 7. pii: S1043-0679(18)30080-7. doi:
10.1053/j.semtcvs.2018.02.034. [Epub ahead of print] PubMed PMID: 29524602.

4: Wells S, Rowin EJ, Boll G, Rastegar H, Wang W, Maron MS, Maron BJ. Clinical
Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic
Cardiomyopathy. Am J Med. 2018 Jan 31. pii: S0002-9343(18)30021-4. doi: 10.1016/j.amjmed.2017.12.031. [Epub ahead of print] PubMed PMID: 29353047.

5: Wells S, Rowin EJ, Boll G, Rastegar H, Wang W, Maron MS, Maron BJ. Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic
Cardiomyopathy. Am J Med. 2018 Jun;131(6):e235-e239. doi: 10.1016/j.amjmed.2017.12.031. Epub 2018 Jan 31. PubMed PMID: 29353047.

III. Interventional Radiology

1: Kagemoto Y, Weintraub A, Pandian NG, Rastegar H, Halin N, Cobey FC. Late Clinical Presentation of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement. J Cardiothorac Vasc Anesth. 2018 Mar 6. pii: S1053-0770(18)30193-9. doi: 10.1053/j.jvca.2018.03.005. [Epub ahead of print] PubMed PMID: 29631945.

1. Annamalai, S. K.; Buiten, L.; Esposito, M. L.; Paruchuri, V.; Mullin, A.; Breton, C.; Pedicini, R.; O'Kelly, R.; Morine, K.; Wessler, B.; Patel, A. R.; Kiernan, M. S.; Karas, R. H.; Kapur, N. K., Acute Hemodynamic Effects of Intra-aortic Balloon Counterpulsation Pumps in Advanced Heart Failure. J Card Fail 2017, 23 (8), 606-614.

2. Avenatti, E.; Iafrati, M. D.; Patel, V.; Little, S. H.; Pandian, N. G.; Ianchulev, S. A., Acute Aortic Syndrome - More in the Spectrum. J Cardiothorac Vasc Anesth 2017, 31 (5), 1735-1739.

3. Bakitas, M.; Dionne-Odom, J. N.; Pamboukian, S. V.; Tallaj, J.; Kvale, E.; Swetz, K. M.; Frost, J.; Wells, R.; Azuero, A.; Keebler, K.; Akyar, I.; Ejem, D.; Steinhauser, K.; Smith, T.; Durant, R.; Kono, A. T., Engaging patients and families to create a feasible clinical trial integrating palliative and heart failure care: results of the ENABLE CHF-PC pilot clinical trial. BMC Palliat Care 2017, 16 (1), 45.

4. Bamberg, F.; Mayrhofer, T.; Ferencik, M.; Bittner, D. O.; Hallett, T. R.; Janjua, S.; Schlett, C. L.; Nagurney, J. T.; Udelson, J. E.; Truong, Q. A.; Woodard, P. K.; Hollander, J. E.; Litt, H.; Hoffmann, U., Age- and sex-based resource utilisation and costs in patients with acute chest pain undergoing cardiac CT angiography: pooled evidence from ROMICAT II and ACRIN-PA trials. Eur Radiol 2018, 28 (2), 851-860.

5. Berger, S. E.; Huggins, G. S.; McCaffery, J. M.; Lichtenstein, A. H., Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials. Am J Clin Nutr 2017, 106 (6), 1337-1346.

6. Bittner, D. O.; Mayrhofer, T.; Bamberg, F.; Hallett, T. R.; Janjua, S.; Addison, D.; Nagurney, J. T.; Udelson, J. E.; Lu, M. T.; Truong, Q. A.; Woodard, P. K.; Hollander, J. E.; Miller, C.; Chang, A. M.; Singh, H.; Litt, H.; Hoffmann, U.; Ferencik, M., Impact of Coronary Calcification on Clinical Management in Patients With Acute Chest Pain. Circ Cardiovasc Imaging 2017, 10 (5).

7. Blanton, R.M., and Alcaide P., Cardiac myosin binding protein C: new roles, new questions, potential opportunities. J Am Coll Cardiol Basic Trans Science: 2017.

8. Blanton, R. M., What can haemodynamic profiles teach us about heart failure in the paediatric population? Eur Heart J 2017, 38 (38), 2910-2911.

9. Burkhoff, D.; Kapur, N. K.; O'Neill, W. W., Methodological Issues and Their Impact on Conclusions. JACC Cardiovasc Interv 2017, 10 (8), 839-841.
10. Butler, J.; Anstrom, K. J.; Felker, G. M.; Givertz, M. M.; Kalogeropoulos, A. P.; Konstam, M. A.; Mann, D. L.; Margulies, K. B.; McNulty, S. E.; Mentz, R. J.; Redfield, M. M.; Tang, W. H. W.; Whellan, D. J.; Shah, M.; Desvigne-Nickens, P.; Hernandez, A. F.; Braunwald, E.; Network, N. H. L. a. B. I. H. F. C. R., Efficacy and Safety of
Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial. JAMA Cardiol 2017, 2 (9), 950-958.

11. Butler, J.; Hamo, C. E.; Udelson, J. E.; O'Connor, C.; Sabbah, H. N.; Metra, M.; Shah, S. J.; Kitzman, D. W.; Teerlink, J. R.; Bernstein, H. S.; Brooks, G.; Depre, C.; DeSouza, M. M.; Dinh, W.; Donovan, M.; Frische-Danielson, R.; Frost, R. J.; Garza, D.; Gohring, U. M.; Hellawell, J.; Hsia, J.; Ishihara, S.; Kay-Mugford, P.; Koglin, J.; Kozinn, M.; Larson, C. J.; Mayo, M.; Gan, L. M.; Mugnier, P.; Mushonga, S.; Roessig, L.; Russo, C.; Salsali, A.; Satler, C.; Shi, V.; Ticho, B.; van der Laan, M.; Yancy, C.; Stockbridge, N.; Gheorghiade, M., Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations. Circ Heart Fail 2017, 10 (4).

12. Chien, WM., Y, L.; AA, D.; MT, C., Injection-Based Delivery of Cell-Permeable Peptide-Tagged Cre. Methods Mol Biol.: 2017.

13. Chokshi, A.; Udelson, J. E., Editorial Commentary: Coronary artery calcification on non-cardiac chest CT: Incidental but impactful. Trends Cardiovasc Med 2017, 27 (7), 481-482.

14. Chow, S. L.; Maisel, A. S.; Anand, I.; Bozkurt, B.; de Boer, R. A.; Felker, G. M.; Fonarow, G. C.; Greenberg, B.; Januzzi, J. L.; Kiernan, M. S.; Liu, P. P.; Wang, T. J.; Yancy, C. W.; Zile, M. R.; Cardiology, A. H. A. C. P. C. o. t. C. o. C.; Sciences, C. o. B. C.; Young, C. o. C. D. i. t.; Nursing, C. o. C. a. S.; Council on Cardiopulmonary, C. C., P.rioperative and Resuscitation; Prevention, C. o. E. a.; Biology, C. o. F. G. a. T.; Research, a. C. o. Q. o. C. a. O., Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2017, 135 (22), e1054-e1091.

15. Cobey, F. C.; Chen, F. Y.; Swaminathan, M., Friday at Five: The Art of Medicine. J Cardiothorac Vasc Anesth 2017, 31 (4), 1334.

16. Cook, J. L.; Colvin, M.; Francis, G. S.; Grady, K. L.; Hoffman, T. M.; Jessup, M.; John, R.; Kiernan, M. S.; Mitchell, J. E.; Pagani, F. D.; Petty, M.; Ravichandran, P.; Rogers, J. G.; Semigran, M. J.; Toole, J. M.; Cardiology, A. H. A. H. F. a. T. C. o. t. C. o. C.; Council on Cardiopulmonary, C. C., P.rioperative and Resuscitation; Young, C. o. C. D. i. t.; Nursing, C. o. C. a. S.; Intervention, C. o. C. R. a.; Anesthesia, a. C. o. C. S. a., Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association. Circulation 2017, 135 (25), e1145-e1158.

17. Covella, M.; Rowin, E. J.; Hill, N. S.; Preston, I. R.; Milan, A.; Opotowsky, A. R.; Maron, B. J.; Maron, M. S.; Maron, B. A., Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy. Circ Heart Fail 2017, 10 (4), e003689.

18. Davel, A. P.; Anwar, I. J.; Jaffe, I. Z., The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease. Curr Opin Nephrol Hypertens 2017, 26 (2), 97-104.

19. de Denus, S.; Rouleau, J. L.; Mann, D. L.; Huggins, G. S.; Cappola, T. P.; Shah, S. H.; Keleti, J.; Zada, Y. F.; Provost, S.; Bardhadi, A.; Phillips, M. S.; Normand, V.; Mongrain, I.; Dubé, M. P., A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. Pharmacogenomics J 2017, 17 (2), 192-200.

20. de Denus, S.; Rouleau, J. L.; Mann, D. L.; Huggins, G. S.; Pereira, N. L.; Shah, S. H.; Cappola, T. P.; Fouodjio, R.; Mongrain, I.; Dubé, M. P., CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. Pharmacogenomics J 2017.

21. Deliargyris, E. N.; Kimmelstiel, C., Heparin or bivalirudin for non-primary PCI: Beware of neat and simple answers…. Catheter Cardiovasc Interv 2017, 90 (3), 378-379.

22. Diaz-Otero, J. M.; Fisher, C.; Downs, K.; Moss, M. E.; Jaffe, I. Z.; Jackson, W. F.; Dorrance, A. M., Endothelial Mineralocorticoid Receptor Mediates Parenchymal Arteriole and Posterior Cerebral Artery Remodeling During Angiotensin II-Induced Hypertension. Hypertension 2017, 70 (6), 1113-1121.

23. Dinca AA, Chien WM, and Chin MT. Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome. J Mol Cell Cardiol.: 2017.

24. DuPont, J. J.; Jaffe, I. Z., 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature. J Endocrinol 2017, 234 (1), T67-T82.

25. Ellis, A. G.; Trikalinos, T. A.; Wessler, B. S.; Wong, J. B.; Dahabreh, I. J., PROPENSITY SCORE-BASED METHODS IN COMPARATIVE EFFECTIVENESS RESEARCH ON CORONARY ARTERY DISEASE. Am J Epidemiol 2017.

26. Ellis, K. L.; Zhou, Y.; Rodriguez-Murillo, L.; Beshansky, J. R.; Ainehsazan, E.; Selker, H. P.; Huggins, G. S.; Cupples, L. A.; Peter, I., Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial. Pharmacogenomics J 2017, 17 (1), 76-83.

27. Esposito, M. L.; Kapur, N. K., Acute mechanical circulatory support for cardiogenic shock: the "door to support" time. F1000Res 2017, 6, 737.

28. Esposito, M.; Bader, Y.; Pedicini, R.; Breton, C.; Mullin, A.; Kapur, N. K., The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock. Indian Heart J 2017, 69 (5), 668-674.

29. Estes NA 3rd, and Madias C.; Atrial Fibrillation in Athletes: A Lesson in the Virtue of Moderation. JACC: Clinical Electrophysiology: 2017.

30. Ferencik, M.; Mayrhofer, T.; Lu, M. T.; Woodard, P. K.; Truong, Q. A.; Peacock, W. F.; Bamberg, F.; Sun, B. C.; Fleg, J. L.; Nagurney, J. T.; Udelson, J. E.; Koenig, W.; Januzzi, J. L.; Hoffmann, U., High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest Pain. Clin Chem 2017, 63 (11), 1724-1733.

31. Fleming, T. R.; DeMets, D. L.; Roe, M. T.; Wittes, J.; Calis, K. A.; Vora, A. N.; Meisel, A.; Bain, R. P.; Konstam, M. A.; Pencina, M. J.; Gordon, D. J.; Mahaffey, K. W.; Hennekens, C. H.; Neaton, J. D.; Pearson, G. D.; Andersson, T. L.; Pfeffer, M. A.; Ellenberg, S. S., Data monitoring committees: Promoting best practices to address emerging challenges. Clin Trials 2017, 14 (2), 115-123.

32. Fleming, T. R.; DeMets, D. L.; Roe, M. T.; Wittes, J.; Calis, K. A.; Vora, A. N.; Meisel, A.; Bain, R. P.; Konstam, M. A.; Pencina, M. J.; Gordon, D. J.; Mahaffey, K. W.; Hennekens, C. H.; Neaton, J. D.; Pearson, G. D.; Andersson, T. L.; Pfeffer, M. A.; Ellenberg, S. S., Rejoinder. Clin Trials 2017, 14 (2), 126-127.

33. Fonarow, G. C.; Konstam, M. A.; Yancy, C. W., The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider. J Am Coll Cardiol 2017, 70 (15), 1931-1934.

34. Fordyce, C. B.; Douglas, P. S.; Roberts, R. S.; Hoffmann, U.; Al-Khalidi, H. R.; Patel, M. R.; Granger, C. B.; Kostis, J.; Mark, D. B.; Lee, K. L.; Udelson, J. E.; Investigators, P. M. I. S. f. E. o. C. P. P., Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol 2017, 2 (4), 400-408.

35. Freeman, L. M.; Rush, J. E.; Stern, J. A.; Huggins, G. S.; Maron, M. S., Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM. Cardiol Res 2017, 8 (4), 139-142.

36. Fu, J.; Upshaw, J.; Cohen, J.; Rodday, A. M.; Saunders, T.; Kelly, M.; Evens, A. M.; Parsons, S. K., Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review. Leuk Lymphoma 2017, 1-5.

37. Gagne, P. J.; Tahara, R. W.; Fastabend, C. P.; Dzieciuchowicz, L.; Marston, W.; Vedantham, S.; Ting, W.; Iafrati, M. D., Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord 2017, 5 (5), 678-687.

38. Ganeshpurkar, A.; Kumar, D.; Singh, S. K., Design, synthesis and collagenase inhibitory activity of some novel phenylglycine derivatives as metalloproteinase inhibitors. Int J Biol Macromol 2018, 107 (Pt B), 1491-1500.
39. Gigliotti, J. N.; Sidhu, M. S.; Robert, A. M.; Zipursky, J. S.; Brown, J. R.; Costa, S. P.; Palac, R. T.; Steckman, D. A.; Malenka, D. J.; Kono, A. T.; Greenberg, M. L., The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study. Clin Cardiol 2017, 40 (10), 861-864.

40. Gil, J. A.; Shah, K. N.; Suarez, L.; Weiss, A. C., Upper-Extremity Extravasation: Evaluation, Management, and Prevention. JBJS Rev 2017, 5 (8), e6.

41. Givertz, M. M.; Fang, J. C.; Sorajja, P.; Dimas, V.; Forfia, P. R.; Kapur, N. K.; Kern, M. J.; Naidu, S. S.; Borlaug, B. A., Executive Summary of the SCAI/HFSA Clinical Expert Consensus Document on the Use of Invasive Hemodynamics for the Diagnosis and Management of Cardiovascular Disease. J Card Fail 2017, 23 (6), 487-491.

42. Gloviczki, P.; Dalsing, M. C.; Henke, P.; Lal, B. K.; O'Donnell, T. F.; Shortell, C. K.; Huang, Y.; Markovic, J.; Wakefield, T. W., Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease. J Vasc Surg Venous Lymphat Disord 2017, 5 (3), 378-398.

43. Good, M. E.; Chiu, Y. H.; Poon, I. K.; Medina, C. B.; Butcher, J. T.; Mendu, S. K.; DeLalio, L. J.; Lohman, A. W.; Leitinger, N.; Barrett, E. J.; Lorenz, U. M.; Desai, B. N.; Jaffe, I. Z.; Bayliss, D.; Isakson, B. E.; Ravichandran, K. S., Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone. Circ Res 2017.

44. Goodson, J.M.; Weldy, C.S.; MacDonald, J.W.; Liu, Y.; Bammler, T.K.; Chien, W.M.; Chin, M.T., In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation. FASEB J: 2017.

45. Gosev, I.; Kiernan, M. S.; Eckman, P.; Soleimani, B.; Kilic, A.; Uriel, N.; Rich, J. D.; Katz, J. N.; Cowger, J.; Lima, B.; McGurk, S.; Brisco-Bacik, M. A.; Lee, S.; Joseph, S. M.; Patel, C. B.; Investigators, E. M. S. R. G. E., Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. Ann Thorac Surg 2017.

46. Hall, S. A.; Uriel, N.; Carey, S. A.; Edens, M.; Gong, G.; Esposito, M.; O'Kelly, R.; Annamalai, S.; Aghili, N.; Adatya, S.; Kapur, N. K., Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. J Heart Lung Transplant 2018, 37 (1), 100-106.

47. Hawwa, N.; Vest, A. R.; Kumar, R.; Lahoud, R.; Young, J. B.; Wu, Y.; Gorodeski, E. Z.; Cho, L., Comparison Between the Kansas City Cardiomyopathy Questionnaire and New
York Heart Association in Assessing Functional Capacity and Clinical Outcomes. J Card Fail 2017, 23 (4), 280-285.

48. Herwald, S. E.; Spies, J. B.; Yucel, E. K., Anticipated Supply and Demand for Independent Interventional Radiology Residency Positions: A Survey of Department Chairs. J Am Coll Radiol 2017, 14 (2), 242-246.

49. Hoffmann, U.; Ferencik, M.; Udelson, J. E.; Picard, M. H.; Truong, Q. A.; Patel, M. R.; Huang, M.; Pencina, M.; Mark, D. B.; Heitner, J. F.; Fordyce, C. B.; Pellikka, P. A.; Tardif, J. C.; Budoff, M.; Nahhas, G.; Chow, B.; Kosinski, A. S.; Lee, K. L.; Douglas, P. S.; Investigators, P., Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation 2017, 135 (24), 2320-2332.

50. Jain, A.; Rohrer, B.; Gebhardt, B.; Breeze, J. L.; Quick, J. D.; Couper, G.; Kiernan, M. S.; Lawrence, M.; Cobey, F. C., Left Ventricular Assist Device Thrombosis Is Associated With an Increase in the Systolic-to-Diastolic Velocity Ratio Measured at the Inflow and Outflow Cannulae. J Cardiothorac Vasc Anesth 2017, 31 (2), 497-504.

51. Jin, H.; Welzig, C. M.; Aronovitz, M.; Noubary, F.; Blanton, R.; Wang, B.; Rajab, M.; Albano, A.; Link, M. S.; Noujaim, S. F.; Park, H. J.; Galper, J. B., QRS/T-wave and calcium alternans in a type I diabetic mouse model for spontaneous postmyocardial infarction ventricular tachycardia: A mechanism for the antiarrhythmic effect of statins. Heart Rhythm 2017, 14 (9), 1406-1416.

52. Jotwani, R.; Boumil, M.; Salem, D.; Wetterhahn, M.; Beninger, P., Theranos Experience Exposes Weaknesses in FDA Regulatory Discretion. Clin Pharmacol Drug Dev 2017, 6 (5), 433-438.

53. Kannappan, M.; Maron, B. J.; Rastegar, H.; Pandian, N. G.; Maron, M. S.; Rowin, E. J., Underappreciated occurrence of discrete subaortic membranes producing left ventricular outflow obstruction in hypertrophic cardiomyopathy. Echocardiography 2017, 34 (8), 1247-1249.

54. Kapur, N. K.; Davila, C. D., Timing, timing, timing: the emerging concept of the 'door to support' time for cardiogenic shock. Eur Heart J 2017, 38 (47), 3532-3534.

55. Kapur, N. K.; Davila, C. D.; Jumean, M. F., Integrating Interventional Cardiology and Heart Failure Management for Cardiogenic Shock. Interv Cardiol Clin 2017, 6 (3), 481-485.

56. Kapur, N. K.; Esposito, M. L.; Bader, Y.; Morine, K. J.; Kiernan, M. S.; Pham, D. T.; Burkhoff, D., Mechanical Circulatory Support Devices for Acute Right Ventricular Failure. Circulation 2017, 136 (3), 314-326.

57. Kiernan, M. S.; Grandin, E. W.; Brinkley, M.; Kapur, N. K.; Pham, D. T.; Ruthazer, R.; Rame, J. E.; Atluri, P.; Birati, E. Y.; Oliveira, G. H.; Pagani, F. D.; Kirklin, J. K.; Naftel, D.; Kormos, R. L.; Teuteberg, J. J.; DeNofrio, D., Early Right Ventricular Assist Device
Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail 2017, 10 (10).

58. Kimmelstiel, C.; Deliargyris, E. N., Bivalirudin versus heparin for peripheral vascular intervention: You get what you pay for…. Catheter Cardiovasc Interv 2017, 89 (3), 414-415.

59. Kimmelstiel, C.; Udelson, J. E., Striking a balance between quality and cost in PCI. Catheter Cardiovasc Interv 2017, 89 (7), 1213-1214.

60. Konstam, M.A.; Kiernan, M.; Chandler, A.; Dhingra, R.; Mody, F.V.; Eisen, H.; Haught, W.H.; Wagoner, L.; Gupta, D.; Patten, R.; Gordon, P.; Korr, K.; Fileccia, R.; Pressler, S.J.; Gregory, D.; Wedge, P.; Dowling, D.; Romeling, M.; Konstam, J.M.; Massaro, J.M.; Udelson, J.E., SECRET of CHF Investigators, Coordinators, and Committee Members. Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol.: 2017.

61. Konstam, M. A., Affordable Care: More Than Just an Act. JACC Heart Fail 2017, 5 (2), 148-151.

62. Konstam, M. A.; Abboud, F. M., Ejection Fraction: Misunderstood and Overrated (Changing the Paradigm in Categorizing Heart Failure). Circulation 2017, 135 (8), 717-719.

63. Konstam, M. A.; Hill, J. A.; Kovacs, R. J.; Harrington, R. A.; Arrighi, J. A.; Khera, A.; Cardiology, A. C. S. L. C. o. t. A. C. o., The Academic Medical System: Reinvention to Survive the Revolution in Health Care. J Am Coll Cardiol 2017, 69 (10), 1305-1312.

64. Konstam, M. A.; Kiernan, M.; Chandler, A.; Dhingra, R.; Mody, F. V.; Eisen, H.; Haught, W. H.; Wagoner, L.; Gupta, D.; Patten, R.; Gordon, P.; Korr, K.; Fileccia, R.; Pressler, S. J.; Gregory, D.; Wedge, P.; Dowling, D.; Romeling, M.; Konstam, J. M.; Massaro, J. M.; Udelson, J. E.; SECRET of CHF Investigators, C. o., and Committee Members, Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol 2017, 69 (11), 1409-1419.

65. Konstam, M. A.; Udelson, J. E., Reply: Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure. J Am Coll Cardiol 2017, 70 (3), 408-409.

66. Kosmidou, I.; Redfors, B.; Selker, H. P.; Thiele, H.; Patel, M. R.; Udelson, J. E.; Magnus Ohman, E.; Eitel, I.; Granger, C. B.; Maehara, A.; Kirtane, A.; Généreux, P.; Jenkins, P. L.; Ben-Yehuda, O.; Mintz, G. S.; Stone, G. W., Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials. Eur Heart J 2017, 38 (21), 1656-1663.

67. Kuchibhotla, S.; Esposito, M. L.; Breton, C.; Pedicini, R.; Mullin, A.; O'Kelly, R.; Anderson, M.; Morris, D. L.; Batsides, G.; Ramzy, D.; Grise, M.; Pham, D. T.; Kapur, N. K., Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock. J Am Heart Assoc 2017, 6 (10).

68. Kumar, K.; Mandleywala, S. N.; Gannon, M. P.; Estes, N. A.; Weinstock, J.; Link, M. S., Development of a Chest Wall Protector Effective in Preventing Sudden Cardiac Death by Chest Wall Impact (Commotio Cordis). Clin J Sport Med 2017, 27 (1), 26-30.

69. Lala, A.; Guo, Y.; Xu, J.; Esposito, M.; Morine, K.; Karas, R.; Katz, S. D.; Hochman, J. S.; Burkhoff, D.; Kapur, N. K., Right Ventricular Dysfunction in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Hemodynamic Analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial and Registry. J Card Fail 2017.

70. Li, D. G.; Wong, G. X.; Martin, D. T.; Tybor, D. J.; Kim, J.; Lasker, J.; Mitty, R.; Salem, D., Attitudes on cost-effectiveness and equity: a cross-sectional study examining the viewpoints of medical professionals. BMJ Open 2017, 7 (7), e017251.

71. Lin, W; Iafrati, MD; Peattie, R; Dorfmann, L., Growth and remodeling with application to AAA. Accepted Journal of Engineering Mathematics 2017.

72. Link, M. S.; Bockstall, K.; Weinstock, J.; Alsheikh-Ali, A. A.; Semsarian, C.; Estes, N. A. M.; Spirito, P.; Haas, T. S.; Rowin, E. J.; Maron, M. S.; Maron, B. J., Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications. J Cardiovasc Electrophysiol 2017, 28 (5), 531-537.

73. Lu, M. T.; Douglas, P. S.; Udelson, J. E.; Adami, E.; Ghoshhajra, B. B.; Picard, M. H.; Roberts, R.; Lee, K. L.; Einstein, A. J.; Mark, D. B.; Velazquez, E. J.; Carter, W.; Ridner, M.; Al-Khalidi, H. R.; Hoffmann, U., Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. J Cardiovasc Comput Tomogr 2017, 11 (5), 373-382.

74. Lu, Q.; Schnitzler, G. R.; Vallaster, C. S.; Ueda, K.; Erdkamp, S.; Briggs, C. E.; Iyer, L. K.; Jaffe, I. Z.; Karas, R. H., Unliganded estrogen receptor alpha regulates vascular cell function and gene expression. Mol Cell Endocrinol 2017, 442, 12-23.

75. Lynch, T. L.; Kuster, D. W. D.; Gonzalez, B.; Balasubramanian, N.; Nair, N.; Day, S.; Calvino, J. E.; Tan, Y.; Liebetrau, C.; Troidl, C.; Hamm, C. W.; Güçlü, A.; McDonough, B.; Marian, A. J.; van der Velden, J.; Seidman, C. E.; Huggins, G. S.; Sadayappan, S., Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary Syndrome. JACC Basic Transl Sci 2017, 2 (2), 122-131.

76. Margoles, L.; DeNofrio, D.; Patel, A. R.; Golan, Y.; Vest, A. R.; Arkun, K.; Boucher, H. W.; Kiernan, M. S.; Upshaw, J. N., Disseminated mucormycosis masquerading as rejection early after orthotopic heart transplantation. Transpl Infect Dis 2017.

77. Maron, M. S., Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better? Circ Cardiovasc Imaging.: 2017.

78. Maron, B. J.; Dearani, J. A.; Maron, M. S.; Ommen, S. R.; Rastegar, H.; Nishimura, R. A.; Swistel, D. G.; Sherrid, M. V.; Ralph-Edwards, A.; Rakowski, H.; Smedira, N. G.; Rowin, E. J.; Desai, M. Y.; Lever, H. M.; Spirito, P.; Ferrazzi, P.; Schaff, H. V., Why we need more septal myectomy surgeons: An emerging recognition. J Thorac Cardiovasc Surg 2017, 154 (5), 1681-1685.

79. Maron, B. J.; Maron, M. S.; Rowin, E. J., Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy. Circulation 2017, 135 (24), 2317-2319.

80. Maron, B. J.; Nishimura, R. A.; Maron, M. S., Shared decision-making in HCM. Nat Rev Cardiol 2017, 14 (3), 125-126.

81. Maron, B. J.; Rowin, E. J.; Maron, M. S.; Braunwald, E., Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is Possible. Am J Med 2017, 130 (11), 1236-1237.

82. Maron, B. J.; Rowin, E. J.; Maron, M. S.; Braunwald, E., Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until Now. Am J Med 2017, 130 (2), 119-123.

83. Maron, M. S.; Rowin, E. J.; Maron, B. J., How to Image Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging 2017, 10 (7).

84. Maron, M. S.; Xin, W.; Sims, K. B.; Butler, R.; Haas, T. S.; Rowin, E. J.; Desnick, R. J.; Maron, B. J., Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy. Am J Med 2018, 131 (2), 200.e1-200.e8.

85. Marston, MA., and O'Donnell TF, HANDBOOK 0F VENOUS AND LYMPHATIC DISORDERS. 4TH EDITION ed.; Gloviczki P [Editor ]: CRC Press New York, 2017.

86. Marzolla, V.; Armani, A.; Mammi, C.; Moss, M. E.; Pagliarini, V.; Pontecorvo, L.; Antelmi, A.; Fabbri, A.; Rosano, G.; Jaffe, I. Z.; Caprio, M., Essential role of ICAM-1 in aldosterone-induced atherosclerosis. Int J Cardiol 2017, 232, 233-242.

87. McCarthy, J.C.; Aronovitz, M.; Dupont, J.J.; Calamaras, T.; Jaffe, I.Z.; Blanton, R.M., Temporary administration of serelaxin improves vascular, but not cardiac, structure and function in the Angiotensin II/L-NAME model of heart failure. JACC: Basic to Translational Science: 2017; Vol. Volume 2.

88. Morin, D. P.; Bernard, M. L.; Madias, C.; Rogers, P. A.; Thihalolipavan, S.; Estes, N. A., In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk Factor. Mayo Clin Proc 2017, 92 (4), 682.

89. Morin, D. P.; Homoud, M. K.; Estes, N. A. M., Prediction and Prevention of Sudden Cardiac Death. Card Electrophysiol Clin 2017, 9 (4), 631-638.

90. Morine, K. J.; Qiao, X.; Paruchuri, V.; Aronovitz, M. J.; Mackey, E. E.; Buiten, L.; Levine, J.; Ughreja, K.; Nepali, P.; Blanton, R. M.; Karas, R. H.; Oh, S. P.; Kapur, N. K., Conditional knockout of activin like kinase-1 (ALK-1) leads to heart failure without maladaptive remodeling. Heart Vessels 2017, 32 (5), 628-636.

91. Morine, K. J.; Qiao, X.; Paruchuri, V.; Aronovitz, M. J.; Mackey, E. E.; Buiten, L.; Levine, J.; Ughreja, K.; Nepali, P.; Blanton, R. M.; Oh, S. P.; Karas, R. H.; Kapur, N. K., Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure. Cardiovasc Pathol 2017, 31, 26-33.

92. Nevers, T.; Salvador, A. M.; Velazquez, F.; Ngwenyama, N.; Carrillo-Salinas, F. J.; Aronovitz, M.; Blanton, R. M.; Alcaide, P., Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure. J Exp Med 2017, 214 (11), 3311-3329.

93. O'Donnell, T.F., and Passman MA, HANDBOOK 0F VENOUS AND LYMPHATIC DISORDERS. (4TH EDITION) ed.; Gloviczki P [Editor ]: CRC Press New York 2017, 2017.

94. O'Donnell, T. F.; Rasmussen, J. C.; Sevick-Muraca, E. M., New diagnostic modalities in the evaluation of lymphedema. J Vasc Surg Venous Lymphat Disord 2017, 5 (2), 261-273.

95. Pancheri, F. Q.; Peattie, R. A.; Reddy, N. D.; Ahamed, T.; Lin, W.; Ouellette, T. D.; Iafrati, M. D.; Luis Dorfmann, A., Histology and Biaxial Mechanical Behavior of Abdominal Aortic Aneurysm Tissue Samples. J Biomech Eng 2017, 139 (3).

96. Penumatsa, K. C.; Toksoz, D.; Warburton, R. R.; Kharnaf, M.; Preston, I. R.; Kapur, N. K.; Khosla, C.; Hill, N. S.; Fanburg, B. L., Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2017, 313 (5), L752-L762.

97. Raff, G. L.; Hoffmann, U.; Udelson, J. E., Trials of Imaging Use in the Emergency Department for Acute Chest Pain. JACC Cardiovasc Imaging 2017, 10 (3), 338-349.

98. Rahban, Y.; Kimmelstiel, C., Real life experience with bioresorbable-polymer everolimus-eluting stents. Is this an answer in search of a question? Catheter Cardiovasc Interv 2017, 90 (6), 888-889.

99. Rahmani, M.; Iafrati, M.D.; Naber, S.P., Glomangioma of the knee with no response to sclerotherapy. Human Pathology: Case Reports 8 (2017) 35–36.

100. 98. Rai, S.; Thaler, D. E.; Salehi, P.; Madan, N.; Leung, L. Y., More to Atherosclerosis Than Stenosis: Symptomatic Carotid Artery With Intraplaque Hemorrhage. Stroke 2017, 48 (4), e104-e107.

101. Rastegar, H.; Boll, G.; Rowin, E. J.; Dolan, N.; Carroll, C.; Udelson, J. E.; Wang, W.; Carpino, P.; Maron, B. J.; Maron, M. S.; Chen, F. Y., Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. Ann Cardiothorac Surg 2017, 6 (4), 353-363.

102. Roehm, B.; Vest, A. R.; Weiner, D. E., Left Ventricular Assist Devices, Kidney Disease, and Dialysis. Am J Kidney Dis 2018, 71 (2), 257-266.

103. Rowin, E. J.; Hausvater, A.; Link, M. S.; Abt, P.; Gionfriddo, W.; Wang, W.; Rastegar, H.; Estes, N. A. M.; Maron, M. S.; Maron, B. J., Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation 2017, 136 (25), 2420-2436.

104. Rowin, E. J.; Maron, B. J.; Arkun, K.; Maron, M. S., Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathy. Eur Heart J 2017, 38 (31), 2444.

105. Rowin, E. J.; Maron, B. J.; Haas, T. S.; Garberich, R. F.; Wang, W.; Link, M. S.; Maron, M. S., Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. J Am Coll Cardiol 2017, 69 (7), 761-773.

106. Rowin, E. J.; Maron, B. J.; Maron, M. S., Reply: Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm. J Am Coll Cardiol 2017, 70 (3), 407.

107. Rowin, E. J.; Maron, B. J.; Olivotto, I.; Maron, M. S., Role of Exercise Testing in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging 2017, 10 (11), 1374-1386.

108. Rowin, E. J.; Maron, M. S.; Chan, R. H.; Hausvater, A.; Wang, W.; Rastegar, H.; Maron, B. J., Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy. Am J Cardiol 2017, 120 (12), 2256-2264.

109. Rowin, E. J.; Orfanos, A.; Estes, N. A. M.; Wang, W.; Link, M. S.; Maron, M. S.; Maron, B. J., Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Am J Cardiol 2017, 119 (11), 1862-1865.

110. Salvador, A. M.; Moss, M. E.; Aronovitz, M.; Mueller, K. B.; Blanton, R. M.; Jaffe, I. Z.; Alcaide, P., Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation. Physiol Rep 2017, 5 (12).

111. Saver, J.L.; Carroll, J.D.; Thaler, D.E.; Smalling, R.W.; MacDonald, L.A.; Marks, D.S.; Tirschwell, D.L., RESPECT Investigators. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med: 2017.

112. Selker, H. P.; Udelson, J. E.; Ruthazer, R.; D'Agostino, R. B.; Nichols, M.; Ben-Yehuda, O.; Eitel, I.; Granger, C. B.; Jenkins, P.; Maehara, A.; Patel, M. R.; Ohman, E. M.; Thiele, H.; Stone, G. W., Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials. Am Heart J 2017, 188, 18-25.

113. Sellamuthu, S.; Singh, M.; Kumar, A.; Singh, S. K., Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery. Expert Opin Ther Targets 2017, 21 (6), 559-570.

114. Serafini, N.; Sharma, P. S.; Madias, C.; Trohman, R. G., Wide complex tachycardia in a patient with congenital heart block: What is the mechanism? J Cardiovasc Electrophysiol 2018, 29 (1), 201-203.

115. Sigurdsson, M. I.; Saddic, L.; Heydarpour, M.; Chang, T. W.; Shekar, P.; Aranki, S.; Couper, G. S.; Shernan, S. K.; Muehlschlegel, J. D.; Body, S. C., Post-operative atrial fibrillation examined using whole-genome RNA sequencing in human left atrial tissue. BMC Med Genomics 2017, 10 (1), 25.

116. Singh, S. K.; Dutta, A.; Modi, G., α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease. Future Med Chem 2017, 9 (10), 1039-1053.

117. Singh, S. K.; Khajuria, R.; Kaur, L., Biodegradation of ciprofloxacin by white rot fungus Pleurotus ostreatus. 3 Biotech 2017, 7 (1), 69.

118. Snarr, B. S.; Liu, M. Y.; Zuckerberg, J. C.; Falkensammer, C. B.; Nadaraj, S.; Burstein, D.; Ho, D.; Gardner, M. A.; Butto, A.; Ewing, S. G.; Pandian, N. G.; Banerjee, A., The Parasternal Short-Axis View Improves Diagnostic Accuracy for Inferior Sinus Venosus Type of Atrial Septal Defects by Transthoracic Echocardiography. J Am Soc Echocardiogr 2017, 30 (3), 209-215.

119. Sorajja, P.; Borlaug, B. A.; Dimas, V. V.; Fang, J. C.; Forfia, P. R.; Givertz, M. M.; Kapur, N. K.; Kern, M. J.; Naidu, S. S., SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease. Catheter Cardiovasc Interv 2017, 89 (7), E233-E247.

120. Sorajja, P.; Borlaug, B. A.; Dimas, V.; Fang, J. C.; Forfia, P. R.; Givertz, M. M.; Kapur, N. K.; Kern, M. J.; Naidu, S. S., Executive summary of the SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease. Catheter Cardiovasc Interv 2017, 89 (7), 1294-1299.

121. Suarez, L.; Tangney, E.; O'Donnell, T. F.; Iafrati, M. D., Cost analysis and implications of routine deep venous thrombosis duplex ultrasound scanning after endovenous ablation. J Vasc Surg Venous Lymphat Disord 2017, 5 (1), 126-133.

122. Swaminathan, M.; Stafford-Smith, M.; Chertow, G.M.; Warnock, D.G.; Paragamian, V.; Brenner, R.M.; Lellouche, F.; Fox-Robichaud, A.; Atta, M.G.; Melby, S.; Mehta, R.L.; Wald, R.; Verma, S.; Mazer, C.D., ACT-AKI investigators. Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. J Am Soc Nephrol.: 2017.

123. Søndergaard, L.; Kasner, S.E.; Rhodes, J.F.; Andersen, G.; Iversen, H.K.; Nielsen-Kudsk, J.E.; Settergren, M.; Sjöstrand, C.; Roine, R.O.; Hildick-Smith, D.; Spence, J.D.; Thomassen, L., Gore REDUCE Clinical Study Investigators. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med.: 2017.

124. Udelson, J. E., Editor's Note. Circ Heart Fail 2017, 10 (6).

125. Udelson, J. E., Left Ventricular Shape: The Forgotten Stepchild of Remodeling Parameters. JACC Heart Fail 2017, 5 (3), 179-181.

126. Udelson, J. E., The Changing Face of Heart Failure. JACC Cardiovasc Imaging 2018, 11 (1), 12-14.

127. Udelson, J. E.; Hoffmann, U., The United Kingdom's National Institute for Health and Care Excellence guideline on chest pain of recent onset: A United States perspective. J Nucl Cardiol 2017, 24 (5), 1535-1539.

128. Upshaw, J.N, "Cardio-Oncology: Protecting the heart from curative cancer treatment. Gland Surgery. : 2017.

129. Upshaw, J. N.; van Klaveren, D.; Konstam, M. A.; Kent, D. M., Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model. Am J Med 2017.

130. Vaduganathan, M.; Harrington, R.A.; Stone, G.W.; Deliargyris, E.N.; Steg, P.G.; Gibson, C.M.; Hamm, C.W.; Price, M.J.; Menozzi, A.; Prats, J.; Elkin, S.; Mahaffey, K.W.; White, H.D.; Bhatt, D.L., CHAMPION Investigators. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. J Am Coll Cardiol.: 2017.

131. van Diepen, S.; Katz, J. N.; Albert, N. M.; Henry, T. D.; Jacobs, A. K.; Kapur, N. K.; Kilic, A.; Menon, V.; Ohman, E. M.; Sweitzer, N. K.; Thiele, H.; Washam, J. B.; Cohen, M. G.; Cardiology, A. H. A. C. o. C.; Nursing, C. o. C. a. S.; Research, C. o. Q. o. C. a. O.; Lifeline, a. M., Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation 2017, 136 (16), e232-e268.

132. Vest, A. R.; Patel, A. R., The Heavy Heart: Metabolic Mechanisms and Myocardial Mechanics. Circ Heart Fail 2017, 10 (5).

133. Wang, W.; Lian, Z.; Rowin, E. J.; Maron, B. J.; Maron, M. S.; Link, M. S., Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol 2017, 10 (3).

134. Weinstock, J.; Madias, C., The Subcutaneous Defibrillator. Card Electrophysiol Clin 2017, 9 (4), 775-783.

135. Weissler-Snir, A.; Hindieh, W.; Gruner, C.; Fourey, D.; Appelbaum, E.; Rowin, E.; Care, M.; Lesser, J. R.; Haas, T. S.; Udelson, J. E.; Manning, W. J.; Olivotto, I.; Tomberli, B.; Maron, B. J.; Maron, M. S.; Crean, A. M.; Rakowski, H.; Chan, R. H., Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging 2017, 10 (2).

136. Wessler BS; Paulus JK; Lundquist C; Ajlan M; Natto Z; Janes WA; Jethmalani N; Raman G; Lutz JS; DM., K., Tufts PACE Clinical Predictive Model Registry: update 1990 through 2015. 2017.

137. Wessler, B. S.; Ruthazer, R.; Udelson, J. E.; Gheorghiade, M.; Zannad, F.; Maggioni, A.; Konstam, M. A.; Kent, D. M., Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure. J Am Heart Assoc 2017, 6 (11).

138. Young, J. B.; Vest, A. R., Is There a Sweet Spot for Left Ventricular Assist Devices and Diabetes Mellitus? Circ Heart Fail 2017, 10 (11).

139. Yucel, E. K., Introducing the New JACR Appropriateness Criteria Supplement. J Am Coll Radiol 2017, 14 (5S), S1.